Vistagen Therapeutics, Inc. VTGN Q1 2025 Annual earnings

FAQ

When did Vistagen Therapeutics, Inc. report Q1 2025 earnings?

Vistagen Therapeutics, Inc. (VTGN) reported Q1 2025 earnings on June 17, 2025 after market close.

What were Vistagen Therapeutics, Inc.'s Q1 2025 revenue and EPS?

Vistagen Therapeutics, Inc. reported revenue of -$15.0K and eps of $-0.43 for Q1 2025.

Did Vistagen Therapeutics, Inc. beat estimates in Q1 2025?

Revenue missed the consensus estimate of $209.3K by $224.3K. EPS beat the consensus estimate of $-0.52 by $0.09.

How did Vistagen Therapeutics, Inc.'s Q1 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 107.6% from $197.3K a year earlier and eps declined 72.0% from $-0.25.

Where can I find Vistagen Therapeutics, Inc.'s Q1 2025 SEC filings?

You can read the 8-K earnings release (0001411685-25-000046) and the 10-K periodic report (0001411685-25-000041) directly on SEC EDGAR. The filing index links above go to sec.gov.